Keyphrases
Tyrosine Kinase Inhibitor
100%
Chronic Myeloid Leukemia
100%
Advanced Phase
100%
Blast Phase
50%
Imatinib
25%
Tyrosine Kinase
25%
Disease Burden
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
25%
Treatment Plan
25%
Chronic Phase
25%
Allogeneic Transplantation
25%
Disease Stage
25%
Difficult-to-treat
25%
Transplant Outcomes
25%
Accelerated Phase
25%
Medicine and Dentistry
Chronic Myelogenous Leukemia
100%
Tyrosine-Kinase Inhibitor
100%
Transplantation
50%
Diseases
50%
Protein Tyrosine Kinase
25%
Disease Burden
25%
Allograft
25%
Imatinib
25%
Allogeneic Stem Cell Transplantation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Protein Tyrosine Kinase Inhibitor
100%
Chronic Myeloid Leukemia
100%
Diseases
75%
Imatinib
25%
Protein Tyrosine Kinase
25%
Biochemistry, Genetics and Molecular Biology
Tyrosine Kinase Inhibitor
100%
Receptor Tyrosine Kinase
33%
Tyrosine Kinase
33%
Cytogenetics
33%
Allogeneic Stem Cell Transplantation
33%
Disease Burden
33%
Imatinib
33%